Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction a ...

Image courtesy of Medtronic] The soon-to-be-separated Medtronic (NYSE: MDT) + Diabetes unit has a new — yet familiar — name, ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...

Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

Medtronic, which announced last month it will spin off its $2.8 billion diabetes unit as a standalone public company, has ...

Medtronic CEO Geoff Martha stated the diabetes business is ‘in a really good spot right now,’ with 6 consecutive quarters of double-digit growth and a robust product pipeline.

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

On May 21, Medtronic announced its intention to separate its Diabetes into an ... its stock price for the following reasons: The Diabetes business manufactures insulin pumps, sensors, continuous ...

Medical-device maker Medtronic plans to separate its diabetes business into a stand-alone company, the company said, in a move that hives off a division that had struggled but recently returned to ...